The significant reduction in the price target for Adicet Bio suggests a downward revision in the expected performance or valuation of the company, which could lead to short-term negative sentiment among investors. However, the maintenance of a Buy rating indicates underlying positive aspects or potential that the analyst sees in the company. The mixed signals could result in short-term volatility in the stock price.